www.InvestorIdeas.com is a meeting place for investors and public companies in leading sectors. Find investing ideas, news and research for biotech stocks, tech and mobile stocks, mining stocks, oil and gas, water stocks, renewable energy, beverage stocks, defense stocks, nanotech and more on the TSX, OTC, NASDAQ and global stock exchanges. We have recently expanded our coverage to include Latin American markets.
Headquartered in New York City’s midtown Manhattan, Dragon Gate Investment Partners is a leading investor relations firm that improves the transparency and consistency of international-oriented Chinese companies. From annual reports to webcast, Dragon Gate helps clients to deliver the right message to the right audience. By targeting the investors via market intelligence database, Dragon Gate improves the trading volume and share valuation for public companies.
The Dragon Gate team consists of investment bankers, Chartered Financial Analysts, media personnel, and IT experts. Our professionals have long standing relations with fund managers, investment bankers, and financial regulators. Our broad range of experience has led to a deep knowledge of US markets and regulations. As an integrated group, Dragon Gate has a deep understanding of the culture difference between the US and China.
private investor....former student in bio tech ....interested in advancing practical and economical sources of treatment for human welfare with dignity an awareness . methodical research can be done with new technology with a much more efficient an timely manner...especially vaccines developed thru research more than a decade ago....Why an Who is creating the lengthy timeline to get these cancer vaccines to patients....We can send discover satellites to another solar system an RETRIEVE the DATA ! WE as a generation are mapping our entire solar system an beyond...OUR government has a duty to protect its citizens not only by man/made laws, but the very law of NATURE demands accountability from its leaders....I am saddened by their methods.!
Graduated from University of Montreal in business administration, I've been an active investor since 1998 after i started my company and made a little bit of money with online Casino's at this time.
I also started to be interested in the small cap investment investors community. I found that when you follow closely a potential company, there is all chances to get benefit out of it and encourage the economic development. One of great teacher at school one day says: " A country is rich because of it's own natural resources" and he his right.
I saw a lot of companies that doesn't it the road. I'm now investors with many companies on the TSX-Venture Stock Exchange. On my blogs, i talk about companies that i've investigate their business model and financial statement and that seems promising when there is a strong team management on board. Obviously there is a plenty of variables that can slow or prevent the developpement of companies as metals prices, the world economic situation, supply and demand and that i think it is great companies with a high potential development.
Hope to see you around and talk to you guys soon by sharing opinions.
Patent News. We publish all the latest insights about patents and patent cases and ways to make profits from trading/investing in these up and coming companies.
Feel free to contact with any questions.
We await your reply.
I have a diverse background—as a financial journalist, resident physician, mixed martial artist, painter, entrepreneur, chemistry instructor and web developer—that enabled me to pioneer the “Integrated Investing Research” approach.
I provide consulting to clients, both the retail and professional investors. I accurately forecasted many clinical trials, such as the Flint Trials for Intercept, the Ascend Trials for InterMune and the Affinity Trials MannKind, just to name a few. Through Vincata Enterprises, LLC, I helped many clients to unlock substantial values for their investments.
As an expert in biopharmaceutical analysis, I am also more than capable of analyzing any other industries. Though not shown on Seeking Alpha, I have picked an aggregate basket of outperforming stocks.
Investing in biotech is highly risky, but it can be quite rewarding when investors have an edge in data analysis. Physicians who are rigidly scientific tend to lack the analytical prowess of financial experts. Conversely, financiers usually do not possess a physician’s medical expertise. Likewise, scientists are skillful in data analysis; yet they might not be familiar with a physician’s prescribing patterns, which is a requisite to successful biotech investing.
You can visit my website at https://www.retailinvestor360.com for business inquiry.
A well rounded investor with a knack for what's coming and what will work. I have an interest in companies with disruptive technology and a variety of other niche players. I have proprietary methods of finding undervalued, and under-appreciated stocks with huge potential.
I have extensively researched the Biotech market the last few years. I look for undervalued stocks,cutting edge science, experienced management and tech to match. With innovation surrounding us in the information age and the advances being made in nano/tech, medicine and computers, I believe many breakthroughs will be made in the coming decade bringing innovation to many sectors in the market.